PLA<sub>2</sub>-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy
Oral medication with activity specifically at the inflamed sites throughout the gastrointestinal tract and limited systemic exposure would be a major advance in our therapeutic approach to inflammatory bowel disease (IBD). For this purpose, we have designed a prodrug by linking active drug moiety to...
Saved in:
Main Authors: | Milica Markovic (Author), Shimon Ben-Shabat (Author), Jagadeesh Nagendra Manda (Author), Karina Abramov-Harpaz (Author), Clil Regev (Author), Yifat Miller (Author), Aaron Aponick (Author), Ellen M. Zimmermann (Author), Arik Dahan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prospects and Challenges of Phospholipid-Based Prodrugs
by: Milica Markovic, et al.
Published: (2018) -
Phospholipid-Based Prodrugs for Colon-Targeted Drug Delivery: Experimental Study and In-Silico Simulations
by: Milica Markovic, et al.
Published: (2019) -
Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products
by: Milica Markovic, et al.
Published: (2020) -
H<sub>2</sub>O<sub>2</sub>-PLA-(Alg)<sub>2</sub>Ca Hydrogel Enriched in Matrigel<sup>®</sup> Promotes Diabetic Wound Healing
by: Alexandra Cătălina Bîrcă, et al.
Published: (2023) -
Identification of a Dual Inhibitor of Secreted Phospholipase A<sub>2</sub> (GIIA sPLA<sub>2</sub>) and SARS-CoV-2 Main Protease
by: Maria A. Theodoropoulou, et al.
Published: (2022)